Daniel de Boer
Fundador en PROQR THERAPEUTICS N.V. .
Fortuna: 1 M $ al 30/04/2024
Cargos activos de Daniel de Boer
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
PROQR THERAPEUTICS N.V. | Director/Miembro de la Junta | - | - |
Director Ejecutivo | 21/02/2012 | - | |
Fundador | 21/02/2012 | - | |
Contacto de Relaciones con Inversores | 21/02/2012 | - |
Historial de carrera de Daniel de Boer
Antiguos cargos conocidos de Daniel de Boer.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Running It | Director Ejecutivo | 01/01/2005 | 01/09/2011 |
Fundador | 01/01/2005 | 01/09/2011 | |
PC Basic B.V. | Director Ejecutivo | 01/02/2006 | 01/02/2008 |
Fundador | 01/02/2006 | 01/02/2008 | |
Amylon Therapeutics BV
Amylon Therapeutics BV Pharmaceuticals: MajorHealth Technology Amylon Therapeutics BV is a biopharmaceutical company, which engages in the research and development of therapies for the central nervous system. It specializes in ribonucleic acid modulation technology to target rare genetic disorders. The company was founded by Thomas de Vlaam and is headquartered in Leiden, the Netherlands. | Fundador | - | - |
Estadísticas
Internacional
Países Bajos | 5 |
Operativa
Founder | 4 |
Chief Executive Officer | 3 |
Director/Board Member | 1 |
Sectorial
Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
PROQR THERAPEUTICS N.V. | Health Technology |
Empresas privadas | 3 |
---|---|
PC Basic B.V. | |
Running It | |
Amylon Therapeutics BV
Amylon Therapeutics BV Pharmaceuticals: MajorHealth Technology Amylon Therapeutics BV is a biopharmaceutical company, which engages in the research and development of therapies for the central nervous system. It specializes in ribonucleic acid modulation technology to target rare genetic disorders. The company was founded by Thomas de Vlaam and is headquartered in Leiden, the Netherlands. | Health Technology |
- Bolsa de valores
- Insiders
- Daniel de Boer
- Experiencia